A novel technique for measuring human tissue pO2 at the cellular level. by Urtasun, R. C. et al.
Br. J. Cancer (1986), 54, 453-457
A novel technique for measuring human tissue pO2 at the
cellular level
R.C. Urtasun, C.J. Koch, A.J. Franko, J.A. Raleigh & J.D. Chapman
Department ofRadiation Oncology, Cross Cancer Institute and Department ofRadiology and Diagnostic
Imaging, University ofAlberta, 11560 University Avenue, Edmonton, Alberta, Canada T6G JZ2
Summary Some electron-affinic drugs, developed as hypoxic cell radiosensitizers, become selectively bound
to the molecules of hypoxic cells by metabolism. This technique has been used to identify zones of chronically
hypoxic cells in multicellular spheroids and animal tumours. Tritiated-misonidazole was administered to a
patient with advanced melanoma 22h prior to the surgical resection of a large metastatic s.c. lesion growing
on the face. Autoradiographic analysis of histological sections revealed zones of intense labelling by the
radioactive drug, indicative of tumour cells which were chronically hypoxic. This technique appears to
provide an indirect measurement of tissue PO2 at the cellular level from which estimates of the tumour
hypoxic fraction can be made. These data are encouraging as regards the development of 'sensitizer-adduct'
procedures for the invasive and non-invasive measurement of hypoxia in both tumours and normal tissues.
The concentration of molecular oxygen in both
normal and neoplastic tissues has important
implications in disease diagnosis and prognosis. In
oncology, for example, hypoxic cells in solid
tumours have been associated with treatment
resistance by radiation (Gray et al., 1953;
Thomlinson & Gray, 1958) and some forms of
chemotherapy (Tannock, 1982). The most direct
technique for measuring tissue oxygen tension
utilizes oxygen electrodes but measurements made
by these techniques can have many limitations
(Cater & Silver, 1960; Chapman et al., 1983b). Even
when microelectrodes are used properly, the oxygen
tension measured would necessarily be an average
value for many cells (related to the volume of tissue
from which oxygen diffuses to the electrode
surface). Histological evaluation of solid tumours
suggests that important changes in cellular pO2 can
occur over dimensions of a few cell diameters
(Tannock, 1968; 1969). The hypoxic cell
radiosensitizer, misonidazole (MISO), was shown to
bind selectively to the molecules of hypoxic cells
(Wong et al., 1978; Miller et al., 1982).
Autoradiographic analysis of radioactive MISO has
been used to identify hypoxic cells in multicellular
spheroids (Franko & Chapman, 1982; Franko et
al., 1982), animal tumours (Chapman et al., 1981;
Horowitz et al., 1983) and in short-term cultures of
human tumour fragments (Franko & Koch, 1984).
This report describes the successful extension of this
technique for labelling hypoxic cells to a cancer
patient.
Materials and methods
A 44-year-old male with multiple, rapidly
progressing subcutaneous deposits of malignant
melanoma consented to receive a dose of 29mCi of
3H-MISO 22h before the surgical resection of a
lesion from his face. 3H-MISO was prepared
according to a published procedure (Bom & Smith,
1982), dissolved in sterile physiological saline and
the solution tested for both sterility and
pyrogenicity. 3H-MISO is as effective a marker for
hypoxic cells as is '4C-MISO (Raleigh el al., 1985;
Rasey et al., 1985). A dose of 74.7mg of 3H-MISO
(specific activity =0.388 mCi mg-1) in 29ml of
sterile physiological saline was administered over
5min into the heparin lock of an indwelling
catheter. The radioactivity in blood and urine was
monitored for 72h. Over the first 24h, 3H-MISO
had a half-life in plasma of 8.7+0.4h and 66%
of the administered radioactivity was excreted in
the urine over the first 72h. Twenty-two hours after
drug administration, a 6 x 5 cm metastatic
melanoma which was fixed to the skin and deep
tissues was totally resected from the left side of the
face. The tumour was cut into smaller pieces and
some were processed by standard histological
procedures. After fixation and embedding in wax,
4,um sections were mounted on microscopic slides,
dipped in liquid emulsion (Kodak NTB3) and
exposed for various times to determine the presence
of 3H-MISO bound to the specimen. Other random
samples from the tumour were processed for liquid
scintillation counting to determine the average
amount of radioactivity in the tumour at the time
of resection. The remainder of the tumour specimen
was cut into cubic fragments of 1-2 mm on the side
for short-term culture in vitro in the presence of
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14C-MISO according to procedures previously
described (Franko & Koch, 1984). After 3 h of
incubation with 50MM 14C-MISO (specific activity
0.23mCimg-1) at 37°C in various concentrations
of oxygen, tumour fragments were fixed in buffered
formalin, embedded in wax, sectioned at 4pm and
processed for 14C-MISO by autoradiography.
Tumour fragment sections were coated with
celloidin, a procedure known to stop 99% of the
beta disintegrations from 3H-MISO. The amount of
14C_MISO bound to tumour cells at the surface of
these tumour fragments and in equilibrium with
known oxygen concentrations served as a 'standard
curve' for MISO binding to this specific tumour
tissue.
Table I 3H-MISO bound in histological sections
of human melanomaa (Kodak NTB3 emulsion, 28
day exposure)
Grains/100 JM2
Area of high grain density
Tumour cells 27.1 +7.7
Stroma 2.0+ 1.7
Area of low grain density
Tumour cells 3.0+2.3
Stroma 1.5+ 1.7
aMeans +s.d. (n =48) less
of 0.21 grains/100pm2.
background exposure
Results
Figures 1 and 2 show autoradiographs of
representative areas of this melanoma. The sections
have been stained with haematoxylin and eosin.
Figures 1 and 2 Autoradiographs of representative
areas from histological sections of a human melanoma
which was labelled with 3H-MISO for 22h prior to
surgical resection. Haematoxylin & eosin ( x 100).
The tumour can be seen to consist of a large
proportion (- 2/3) of anaplastic tumour cells
interspersed amongst a smaller proportion (-1/3)
of vascular and stromal elements. Large deposits of
melanin were observed in random patterns which
did not correlate with any specific histological
feature and no necrosis was detected. It is apparent
that the emulsion overlying these tumour sections
has been variably exposed, by differing
concentrations of fixed 3H-MISO in the underlying
tumour tissue. Table I shows the average number of
grains/lO0pm2 for regions of the tumour which
were judged at low magnification to be densely
labelled and sparsely labelled. Measurements of
grains/!100 m2 over tumour stroma adjacent to the
densely and sparsely labelled tumour cells are also
given. A ratio of - 9 is observed between the
average amount of 3H-MISO bound to tumour
cells in the densely labelled areas compared to the
sparsely labelled areas. It is interesting to note that
the stromal tissue adjacent to densely labelled
tumour cells and presumably equally hypoxic is
sparsely labelled by this drug. This effect has been
observed in short-term cultures of a well
differentiated rat prostatic adenocarcinoma and a
human colon carcinoma (Franko & Koch, 1984).
This difference in labelling efficiency between
hypoxic tumour and hypoxic stromal tissue may
result from a much lower proportion of viable cells
(and a larger proportion of extracellular matrix
molecules) in stromal tissue or from an inherent
difference in sensitizer metabolism between the
tissues.
The hypoxic fractions of animal tumours are
most commonly determined by radiobiological
procedures (Moulder & Rockwell, 1984). These
techniques cannot be utilized for estimating the
hypoxic fraction of an individual human tumour.
The variable binding of 3H-MISO seen in Figures 1
and 2 was analyzed to yield an estimate of hypoxic
fraction. Using a value of 10 grains/100 pm2 and
greater as indicative of hypoxia, the percentage ofHUMAN TUMOUR HYPOXIA MEASUREMENT 455
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Figure 3 A 'standard curve' for '4C-MISO binding to
this human melanoma as a function of oxygen
concentration. Grains/l00pm2 is plotted versus
concentration of oxygen (% in gas phase) and error
bars indicate s.d.
histological cross-sections (50 different microscopic
fields) which met this criterion was - 6%. A
determination of densely labelled tumour cells using
a technique of Chalkley counting gave a value of
-5.8%. In the absence of an independent
procedure for measuring the hypoxic fraction of a
single tumour, it is difficult to estimate how close
these values might be to a more traditional value of
tumour hypoxic fraction based upon radiobiological
resistance. In this regard, Figure 3 shows the
number of grains/100pm2 over tumour cells in
short-term 'tissue culture' exposed to 50pM 14C_
MISO at various oxygen concentrations. The km
value for inhibition of adduct formation is -0.1%
oxygen. The concentration of labelled sensitizer and
time of exposure are important factors in determin-
ing the amount of sensitizer fixed to a specific cell
(Chapman et al., 1983a). Consequently, the in vitro
binding data in Figure 3 cannot be directly
compared to the in vivo binding data in Table I
(drug concentrations and exposure times were quite
different). If we assume that the areas within this
tumour which are densely labelled in vivo (Table I)
correspond to the maximum for tissue labelling in
vitro we can define a scale factor of - 2.1
(27.1 +7.7 grains per 100l m2/12.8+2.9 grains per
100pm2) between the two data sets. Then the
sparsely labelled areas of this melanoma (in vivo)
would have an average pO2 of -2%, a value
obtained from Figure 3 for 1.4 grains/100pm2 (3.0
grains/l00ym2 divided by the scale factor of 2.1).
Since the oxygen level in capillary blood is 5-8%
an average value of 2% for oxygenated tumour
tissue is quite reasonable. This analysis also
suggests that tumour tissue labelled with 10
grains/IOO pm2 and greater (in vivo) would contain
oxygen concentrations of <0.2% (grain densities of
5 grains/I00pm2 and greater in Figure 3) which
would be expected to be radiobiologically resistant.
Of course, cells in these regions of this tumour
would only contribute to treatment resistance by
radiation or chemotherapy if they were clonogenic.
The amount of 3H per gram of tumour tissue at the
time of resection was 1.6+0.1 times greater than
the amount of 3H per gram in plasma which might
be indicative of hypoxic cell activation and adduct
formation to the hypoxic cell compartment of this
tumour. This parameter based upon liquid
scintillation measurements could become a rapid
assay for tumour hypoxic fraction.
Figures 4 and 5 show high power views of
selected areas of the tumour specimen. The
variation in label density from tumour cell to
tumour cell and the much lower uptake of 3H-
MISO into stromal tissue is apparent. In these
Figure 4 Autoradiograph of selected area of human
melanoma labelled with 3H-MISO for 22h prior to
surgical resection. Haematoxylin & eosin (x400).
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Figure 5 Autoradiograph of selected area of human
melanoma labelled with 3H-MISO for 22h prior to
surgical resection. Haematoxylin & eosin ( x 600).456 R.C. URTASUN et al.
microscopic fields, cells which are maximally
labelled and assumed to be severely hypoxic can be
observed adjacent to blood vessels. These data
suggest that blood flow through these 'apparently
healthy' vessels was restricted over much of the 22h
labelling interval. Blood flow through such vessels
may have been restricted because of specific
damage to the vessel wall at a distance from this
specific section or from vessel collapse due to
intratumour pressures.
Discussion
This technique of sensitizer-adduct formation in
hypoxic tissue has now been used to study resected
tumour specimens from 9 different patients.
Hypoxic fractions were identified in only 4 of the 9
tumours analyzed. A total of 15-20 human tumours
will be introduced into this study before an attempt
is made to correlate tumour pathology and/or
tumour treatment sensitivity with hypoxic fraction.
These data suggest that this novel technique may be
useful in determining tissue pO2 at the cellular level
in human tumours and possibly in other normal
tissues. However, because of its invasive nature, the
requirement for a relatively large sample and the
several weeks of time required for autoradiographic
exposure, the procedure used in this study will have
limited clinical use. More rapid analyses for
sensitizer adducts in tumour specimens will be
required and are under development.
It would be useful if the sensitizer adduct
procedure for determining tissue oxygenation status
could be correlated with another procedure. With
animal models we propose to investigate the
relationship between sensitizer adduct concentra-
tions in tumour tissues and measurements made
with oxygen microelectrodes. It is our opinion that
no other assay currently exists for measuring tissue
PG2 at the cellular level. The standard curve in
Figure 3 was generated utilizing a 3h incubation of
tumour tissue fragments in the presence of 14C_
MISO. At least a 15-fold difference in labelling
between tumour fragments incubated in <0.10%
02 and under aerobic conditions was observed. The
areas of high grain density in the tumour specimens
labelled in situ are probably indicative of zones of
chronic hypoxia. If transient hypoxia (<1 h)
occurred within this tumour, it is unlikely that this
sensitizer adduct technique could identify such
zones.
This technique could have wide application in
oncology and disease states of normal tissues if
sensitizer adducts to hypoxic or ischaemic tissues
could be detected by non-invasive procedures
(Chapman, 1984). The details of tissue pO2 at the
cellular level measured by this technique should
prove useful in predicting the potential of magnetic
resonance spectroscopy (MRS) and positron
emission tomography (PET) procedures being
developed for the measurement of tissue hypoxia.
MRS, PET and other imaging procedures can
currently measure 'signal' averages from tissue
volumes of 0.1-1.Ocm3 (- 108-109 cells).
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